Delivery Order SPE2DB20D2104-SPE2DB23FU55B

Award Date 7/25/23
Potential Completion Date 7/26/23
Potential Value $1.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under a Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract provides for the delivery of Trulicity 4.5 mg/0.5 ml pens, a specialty medication for diabetes management. The contract has a ceiling value of $1,741.68 and a completion date of December 19, 2023. This award is not designated as a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $10,814.68 firm-fixed-price delivery order is for the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen 0.5 ml. The contract has an ultimate completion date of April 12, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC is valued at up to $999,999,999.00 and runs through November 2026. This specific delivery order is for Trulicity 1.5 mg/0.5 ml pens, with a ceiling value of $2,829.65. The contract has a firm fixed price pricing type and does not have a set-aside designation,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract provides for the delivery of 4,563,118,096 units of the pharmaceutical product Trulicity 3 mg/0.5 ml pen, with a ceiling value of $9,271.68. The contract has a period of performance through December 18, 2023 and is a Firm Fixed Price...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,306.26 and covers the supply of Trulicity 3 mg/0.5 ml pen 0.5 ml, a prescription medication used to manage diabetes. The award has an ultimate completion date of May 14, 2024. This contract is part of a larger $999,999,999 IDC held by Cencora,...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract, valued at $2,467.38, is for the delivery of the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen 0.5 ml. The contract has a completion date of January 3, 2024 and is a firm-fixed-price delivery order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is a Delivery Order valued at $3,606.40, placed by the Defense Logistics Agency (DLA) for the supply of Trulicity 1.5 mg/0.5 ml pens. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Trulicity 3 mg/0.5 ml pens for the Defense Logistics Agency (DLA). The single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally....
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,081.92 for the supply of the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen 0.5 ml. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $6,447.53 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) for the supply of Trulicity 1.5 mg/0.5 ml pen 0.5 ml. The contract has an ultimate completion date of January 18, 2023. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB23FU55B
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract covers the supply of Trulicity 0.75 mg/0.5 ml pen to DLA facilities supporting the Department of Defense (DoD) and other federal medical institutions. The award has a ceiling value of $1,242.60 and a completion date of July 26, 2023. This contract is awarded on a full and open competition basis, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the DLA and the Department of Justice Federal Bureau of Investigation, through various IDCs.

Generated 2/27/25, 11:30 AM